Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
Drugs@FDA (Enter "glatiramer acetate" in search box.)
Risks of immune system treatments.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis.
Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis.
Rapid exacerbation of neuromyelitis optica after rituximab treatment.
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Monoclonal antibodies in MS: mechanisms of action.
Estrogen treatment in multiple sclerosis.
Spectrum of nontraumatic myelopathies in Ethiopian patients: hospital-based retrospective study.
Treatment satisfaction in multiple sclerosis.
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Anti-JCV antibody levels in serum or plasma further define risk of natalizumab-associated PML.
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
Visualizing Non-Gaussian Diffusion: Clinical Application of q-Space Imaging and Diffusional Kurtosis Imaging of the Brain and Spine.
Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells.
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.
Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.

Pages